Cooling the German Discussion

Cooling the German discussion A unique network that includes philosophers, lawyers and theologians as well as scientists is helping stem cell research in North Rhine-Westphalia to proceed in the face of stiff opposition. By Cormac Sheridan Embryonic stem (ES) cells need extrinsic growth signals. ES cells are shown cultured in the presence (left) and absence (right) of the cytokine LIF (leukemia inhibitory factor). LIF maintains the ES cell's key properti

Written byCormac Sheridan
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

By Cormac Sheridan

In 2001, Oliver Brüstle, a prominent German stem cell scientist, and Wolfgang Clement, then prime minister of the state of North Rhine-Westphalia (NRW), caught a plane to Israel. The purpose of the trip was to pay a visit to stem cell pioneer Joseph Itskovitz-Eldor at the Technion Israel Institute of Technology, in Haifa. However, its significance goes far beyond the specifics of the exchange that occurred between two scientists and a politician. In retrospect, it can be seen as the moment when Germany's full participation in the field of stem cell research was underwritten.

In 2008, Hans Schöler, Director of the Department of Cell and Developmental Biology at the Max Planck Institute for Molecular Biomedicine, in Münster, shared the Robert Koch Prize with Irving Weissman and Shinya Yamanaka for their critical contributions to stem cell biology. Schöler was the first to derive germline cells from murine embryonic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies